tirzepatide maximum weight loss surmount trials SURMOUNT-3 study design This is a phase 3, multicenter, randomized, SURMOUNT-1 Trial - Cardionerds Twitter

The three-year study of 1,032 adults showed that weekly injections of tirzepatide cut the risk of developing Type 2 diabetes by 94% in prediabetic adults who were overweight or obese, compared to placebo

Patients using continuous glucose monitors may observe changes in glycemic patterns during the week following a missed injection

You round to the nearest whole number, consistently rounding up or down

The manufacturing process itself is highly complex, involving a 39 amino acid synthetic peptide created through solid-phase synthesis or block approaches

But it also means food sits in your stomach longer than your body is accustomed to